Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-01-24 @ 11:34 AM
Study NCT ID:
NCT02486718
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-10
First Post:
2015-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2035-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2015-06-04
First Submit QC Date:
None
Study First Post Date:
2015-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-12-12
Results First Submit QC Date:
None
Results First Post Date:
2025-03-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-30
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED